REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |
| Rhenman & Partners Asset Management AB | 388,000 | $8,656,000 | 0.91% |
| Monashee Investment Management LLC | 85,000 | $2,295,000 | 0.85% |
| Integral Health Asset Management, LLC | 150,000 | $4,050,000 | 0.79% |
| Polar Capital Holdings Plc | 4,461,747 | $120,467,000 | 0.77% |
| Perceptive Advisors | 808,671 | $21,834,000 | 0.63% |
| EAM Investors, LLC | 94,413 | $2,549,000 | 0.55% |
| Ikarian Capital, LLC | 100,000 | $2,700,000 | 0.54% |
| EAM Global Investors LLC | 63,279 | $1,709,000 | 0.45% |
| MOODY ALDRICH PARTNERS LLC | 79,984 | $2,160,000 | 0.44% |
| Caption Management, LLC | 1,161,200 | $31,352,000 | 0.43% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.